Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tenofovir/adverse effects"'
Autor:
Surial, Bernard, Cavassini, Matthias, Calmy, Alexandra, Fehr, Jan, Stöckle, Marcel, Bernasconi, Enos, Roth, Bianca, Fux, Christoph A, Kovari, Helen, Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles, Swiss HIV Cohort Study
Publikováno v:
BMC infectious diseases, vol. 19, no. 1, pp. 834
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9
BackgroundTenofovir alafenamide (TAF)-containing combinations were introduced in Switzerland after October 2016 and are recommended over tenofovir disoproxil fumarate (TDF) in patients with osteoporosis or impaired renal function.MethodsWe included a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e4872fd47d082fd5c4208de5eb56dc
https://serval.unil.ch/resource/serval:BIB_33535700F126.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_33535700F126.P001/REF.pdf
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R Tenorio, Keith Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Smith, Lidia Cassetti, Daniel David, Laura Figueras, Marcelo Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, David Cooper, Robert Finlayson, Anthony Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matthew Shields, Stephane De Wit, Eric Florence, Jean-Christophe Goffard, Remy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan Angel, Jean-Guy Baril, Brian Conway, Alexandra De Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cecile Goujard, Christine Katlama, Jean-Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph Spinner, Hans-Jurgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan Den Hollander, Bart Rijnders, José A Hidalgo, Luis Hercilla Vasquez, Luis Illescas, Anita Olczak, Kamal Mansinho, Patricia Paula Correia Pacheco, Eugénio Teófilo, Jose Saraiva da Cunha, Rui Sarmento e Castro, Rosário Serrão, Manuela Arbune, Cristian Jianu, Anca Oprea, Liliana Preotescu, Liviu-Jany Prisacariu, Elena Belonosova, Olga Borodkina, Oxana Chernova, Natalia Gankina, Svetlana Kizhlo, Valeriy Kulagin, Nadezhda Kurina, Firaya Nagimova, Vadim Pokrovsky, Elena Ryamova, Evgeny Voronin, Alexey Yakovlev, Richard Kaplan, Sun Hee Lee, Shin-Woo Kim, Sang-Il Kim, Woo Joo Kim, Antonio Antela Lopez, Jose L Casado Osorio, Manuel A Castaño Carracedo, Ignacio De Los Santos Gil, Vicente Estrada Perez, Vicenç Falco Ferrer, Luis Force, Maria Jose Galinda Puerto, Miguel Garcia Deltoro, Josep M Gatell, Miguel A Goenaga Sanchez, Ana González Cordón, Hernando Knobel, Juan Carlos Lopez Bernaldo de Quiros, Juan E Losa Garcia, Mar Masia, Marta Montero-Alsonso, Antonio Ocampo Hermida, Juan Pasquau Liaño, Joaquin Portilla Sogorb, Federico Pulido Ortega, Antonio Rivera Roman, Jose Ramon Santos Fernandez, Rafael Torres Perea, Jesus Troya Garcia, Pompeyo Viciana Fernandez, Alexandra Calmy, Christoph Hauser, Jan Fehr, Shu-Hsing Cheng, Wen-Chien Ko, Hsi-Hsun Lin, Po-Liang Lu, Yu-Ting Tseng, Ning-Chi Wang, Wing-Wai Wong, Chia-Jui Yang, Roberto Arduino, Paul Benson, Mezgebe Berhe, Fritz Bredeek, Cynthia Brinson, Thomas Campbell, Gordon Crofoot, Douglas Cunningham, Edwin DeJesus, Robin Dretler, Joseph Eron, Kenneth Fife, Carl Fichtenbaum, Jason Flamm, Deborah Goldstein, Samir Gupta, Debbie Hagins, Margaret Hoffman-Terry, Dushyantha Jayaweera, Clifford Kinder, Daniel Klein, Cheryl McDonald, Anthony Mills, Ronald Nahass, Olayemi Osiyemi, Edgar Overton, David Parks, David Prelutsky, Moti Ramgopal, Shannon Schrader, Beverly Sha, Gary Simon, James Sims, Daniel Skiest, Jihad Slim, Karen Tashima, Blair Thedinger, Brian Gazzard, Julie Fox, Margaret Johnson, Stephen Kegg, Saye Khoo, Charles Mazhude, Chloe Orkin, Gabriel Schembri, Andrew Ustianowski
Publikováno v:
The Lancet, 393(10167), 143-155. Elsevier Ltd.
Summary Background Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad70b60db548619c808fac0879d6106
https://hdl.handle.net/11380/1221490
https://hdl.handle.net/11380/1221490
Autor:
Eric Florence, Jens D Lundgren, P. Gargalianos-Kakolyris, Court Pedersen, Fernando Maltez, V. Uzdaviniene, Thérèse Staub, for EuroSIDA, Jennifer F Hoy, Leo Flamholc, G. Kyselyova, Hans Jürgen Stellbrink, Rainer Weber, J Tomazic, Chloe Orkin, Anna Lisa Ridolfo, Fiona Mulcahy, Christian Pradier, Patrick Schmid, Dalibor Sedláček, Álvaro H. Borges, Amanda Mocroft, Clifford Leen
Publikováno v:
Borges, Á H, Hoy, J F, Florence, E, Sedlacek, D, Stellbrink, H-J, Uzdaviniene, V, Tomazic, J, Gargalianos-Kakolyris, P, Schmid, P, Orkin, C, Pedersen, C, Leen, C, Pradier, C, Mulcahy, F, Ridolfo, A L, Staub, T, Maltez, F, Weber, R, Flamholc, L, Kyselyova, G, Lundgren, J D, Mocroft, A & for EuroSIDA 2017, ' Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort ', Clinical Infectious Diseases, vol. 64, no. 10, pp. 1413-1421 . https://doi.org/10.1093/cid/cix167
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Background: Antiretrovirals (ARVs) affect bone density and turnover, but their effect on risk of fractures and osteonecrosis of the femoral head is less understood. We investigated if exposure to ARVs increases the risk of both bone outcomes. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192623243970f6512cea9fa1488b96bd
https://findresearcher.sdu.dk:8443/ws/files/141377132/Antiretrovirals_Fractures_and_Osteonecrosis_in_a_Large_International_HIV_Cohort.pdf
https://findresearcher.sdu.dk:8443/ws/files/141377132/Antiretrovirals_Fractures_and_Osteonecrosis_in_a_Large_International_HIV_Cohort.pdf
Autor:
Jinell Mah Ming, Yaping Chang, Yung Lee, Arnav Agarwal, Farid Foroutan, Elliot Hepworth, Reed A C Siemieniuk, Yuan Zhang, Dena Zeraatkar, Paul E. Alexander, Arnaud Merglen, Reza Mirza, Hassan Mir, Olufunmilayo A. Lesi, Gordon H. Guyatt
Publikováno v:
BMJ Open, Vol. 7, No 9 (2017) P. e019022
BMJ Open
BMJ Open
ObjectiveTo assess the impact of various antiretroviral/antiviral regimens in pregnant women living with HIV or hepatitis B virus (HBV).DesignWe performed random effects meta-analysis for HIV-related outcomes and network meta-analysis for HBV outcome